Methods and compositions for detecting compounds that modulate inflammatory responses
    1.
    发明授权
    Methods and compositions for detecting compounds that modulate inflammatory responses 失效
    用于检测调节炎症反应的化合物的方法和组合物

    公开(公告)号:US07273712B2

    公开(公告)日:2007-09-25

    申请号:US10026335

    申请日:2001-12-21

    IPC分类号: C12Q1/02 G01N33/53

    摘要: The present invention relates to compositions and methods for identification and development of compounds or therapeutic agents that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to methods for detecting compounds or therapeutic agents that inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in cells. The present invention provides compositions for and methods of treatment of biological conditions including, but not limited to, vascular complications of type I and type II diabetic induced vasculopathies, other vasculopathies, microangiopathies, renal insufficiency, Alzheimer's syndrome, and inflammation-induced diseases such as atherosclerosis.

    摘要翻译: 本发明涉及用于鉴定和开发用于治疗由炎性反应引起的病理生理状况的化合物或治疗剂的组合物和方法。 特别地,本发明涉及用于检测化合物或治疗剂的方法,所述化合物或治疗剂抑制或阻断糖化蛋白质产生细胞中信号传导相关炎症反应的诱导。 本发明提供了用于治疗生物学条件的组合物和治疗方法,包括但不限于I型和II型糖尿病诱导的血管病变,其他血管病变,微血管病,肾功能不全,阿尔茨海默氏综合征和炎症诱发的疾病如 动脉粥样硬化。

    Methods and compositions for the treatment of inflammatory diseases
    2.
    发明授权
    Methods and compositions for the treatment of inflammatory diseases 失效
    用于治疗炎性疾病的方法和组合物

    公开(公告)号:US06900041B2

    公开(公告)日:2005-05-31

    申请号:US09969013

    申请日:2001-10-02

    摘要: The present invention is directed to compositions and methods for treating inflammatory diseases comprising administration of compositions that effect glycogen synthase kinase 3β (GSK-3β) protein or gene. The present invention also comprises methods and compositions for the identification of compounds or therapeutic agents which modulate the activity of the protein. The present invention provides compositions for and methods off treatment of biological conditions including, but not limited to, type I and type II diabetic induced vasculopathy, other vasculopathies, asthma and inflammation-induced diseases such as atherosclerosis and cell proliferation.

    摘要翻译: 本发明涉及用于治疗炎性疾病的组合物和方法,包括施用影响糖原合酶激酶3β(GSK-3β)蛋白或基因的组合物。 本发明还包括用于鉴定调节蛋白质活性的化合物或治疗剂的方法和组合物。 本发明提供了生物学条件的组合物和方法,包括但不限于I型和II型糖尿病诱发的血管病变,其它血管病变,哮喘和炎性引起的疾病如动脉粥样硬化和细胞增殖。